Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Turkey

Multinationals Eye Turkish Drug market

April 2006 | Company Finance Alert

Turkey's drug market is attracting the attention of global investors after growing by 33% in 2005. US drugmaker Valeant is planning to launch its neurological products, while Sandoz - the generics division of Swiss drug firm Novartis - has recently decided to return to the market after a

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries